D. Boral Capital Reiterates “Buy” Rating for Beyond Air (NASDAQ:XAIR)

D. Boral Capital reaffirmed their buy rating on shares of Beyond Air (NASDAQ:XAIR) in a research report report published on Thursday morning,Benzinga reports. D. Boral Capital currently has a $11.00 target price on the stock.

Other equities analysts have also issued research reports about the stock. Wall Street Zen lowered shares of Beyond Air from a “hold” rating to a “sell” rating in a research report on Saturday, August 16th. D Boral Capital raised shares of Beyond Air to a “strong-buy” rating in a report on Thursday, July 17th. One analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. Based on data from MarketBeat, Beyond Air presently has a consensus rating of “Strong Buy” and an average price target of $11.00.

Beyond Air Price Performance

Shares of NASDAQ:XAIR opened at $2.25 on Thursday. The company has a quick ratio of 2.71, a current ratio of 3.24 and a debt-to-equity ratio of 0.92. The firm has a market capitalization of $11.77 million, a PE ratio of -0.19 and a beta of 0.25. Beyond Air has a twelve month low of $2.02 and a twelve month high of $13.52. The company has a 50-day moving average price of $3.26 and a two-hundred day moving average price of $4.38.

Beyond Air (NASDAQ:XAIR) last issued its earnings results on Tuesday, August 12th. The company reported ($1.53) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.50) by ($0.03). The business had revenue of $1.76 million for the quarter, compared to the consensus estimate of $1.75 million. Beyond Air had a negative return on equity of 232.61% and a negative net margin of 880.72%. Beyond Air has set its FY 2026 guidance at EPS. Equities analysts forecast that Beyond Air will post -0.79 EPS for the current year.

Institutional Investors Weigh In On Beyond Air

Institutional investors and hedge funds have recently modified their holdings of the company. Geode Capital Management LLC raised its stake in Beyond Air by 81.0% in the fourth quarter. Geode Capital Management LLC now owns 562,713 shares of the company’s stock valued at $202,000 after purchasing an additional 251,823 shares in the last quarter. Alyeska Investment Group L.P. purchased a new stake in Beyond Air in the fourth quarter valued at approximately $2,560,000. Balyasny Asset Management L.P. purchased a new stake in Beyond Air in the fourth quarter valued at approximately $1,195,000. Squarepoint Ops LLC purchased a new stake in Beyond Air in the fourth quarter valued at approximately $48,000. Finally, Wealthedge Investment Advisors LLC purchased a new stake in Beyond Air in the fourth quarter valued at approximately $80,000. 31.50% of the stock is owned by hedge funds and other institutional investors.

Beyond Air Company Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.